Because fat accumulation in the liver may affect insulin clearance [9], it has long been debated whether impaired insulin clearance in patients with NAFLD is one of the causes of hyperinsulinemia [10]. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.